• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[急性间歇性卟啉病]

[Acute intermittent porphyria].

作者信息

Sugimura K

机构信息

Nagoya University College of Medical Technology.

出版信息

Nihon Rinsho. 1995 Jun;53(6):1418-21.

PMID:7616656
Abstract

The clinical features of acute intermittent porphyria (AIP) are described in this chapter. AIP is inherited as an autosomal dominant pattern of inheritance. Prevalence in Japan is 1.5 in 100,000. Attacks are more frequent in women of 20s to 40s. The common clinical pattern of symptom involves acute abdominal pain, psychiatric disturbances, and acute neuropathy. The nerve biopsy shows segmental demyelination and axonal degeneration. Many small vacuolations are distinctively seen in all of the cell components of the nerve. Clinical diagnosis is not difficult when doctors keep the possibility of AIP in their minds in cases of abdominal pain, weakness and mental symptoms. The major trust of treatment is avoidance of acute attacks which is almost entirely dependent upon avoidance of porphyrogenic drugs. The intravenous administration of heme and glucose is important and effective therapy for acute attacks of porphyria.

摘要

本章描述了急性间歇性卟啉病(AIP)的临床特征。AIP以常染色体显性模式遗传。在日本,其患病率为十万分之一点五。20多岁至40多岁的女性发作更为频繁。常见的症状模式包括急性腹痛、精神障碍和急性神经病变。神经活检显示节段性脱髓鞘和轴突变性。在神经的所有细胞成分中都能明显看到许多小空泡。当医生在遇到腹痛、虚弱和精神症状时考虑到AIP的可能性,临床诊断并不困难。治疗的主要要点是避免急性发作,这几乎完全依赖于避免使用致卟啉药物。静脉注射血红素和葡萄糖是治疗卟啉病急性发作的重要且有效的疗法。

相似文献

1
[Acute intermittent porphyria].[急性间歇性卟啉病]
Nihon Rinsho. 1995 Jun;53(6):1418-21.
2
Acute intermittent porphyria.急性间歇性卟啉病
Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):235-49. doi: 10.1016/j.bpg.2004.10.006.
3
Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.血液透析:发展中国家急性间歇性卟啉症严重发作的一种治疗选择。
Hemodial Int. 2008 Jan;12(1):34-8. doi: 10.1111/j.1542-4758.2008.00237.x.
4
Acute intermittent porphyria.急性间歇性卟啉病
Semin Liver Dis. 1998;18(1):17-24. doi: 10.1055/s-2007-1007136.
5
Acute intermittent porphyria: psychosis as the only clinical manifestation.急性间歇性卟啉病:以精神病为唯一临床表现
Isr J Psychiatry Relat Sci. 2006;43(1):52-6.
6
Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.血浆胆色素原作为监测急性间歇性卟啉病发作的临床及治疗过程的敏感生物标志物。
Eur J Intern Med. 2009 Mar;20(2):201-7. doi: 10.1016/j.ejim.2008.06.012. Epub 2008 Aug 8.
7
Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria.将胆色素原脱氨酶互补脱氧核糖核酸以非病毒方式导入急性间歇性卟啉症小鼠模型。
Mol Genet Metab. 2004 May;82(1):20-6. doi: 10.1016/j.ymgme.2004.02.008.
8
[Acute intermittent porphyria: a possible cause of abdominal pain].[急性间歇性卟啉病:腹痛的一个可能原因]
Gastroenterol Hepatol. 1999 Dec;22(10):497-500.
9
[Acute intermittent porphyria].
Tidsskr Nor Laegeforen. 2002 Apr 30;122(11):1102-5.
10
Molecular diagnostics of acute intermittent porphyria.急性间歇性卟啉症的分子诊断
Expert Rev Mol Diagn. 2004 Mar;4(2):243-9. doi: 10.1586/14737159.4.2.243.

引用本文的文献

1
Estimating carrier rates and prevalence of porphyria-associated gene variants in the Chinese population based on genetic databases.基于遗传数据库估计中国人群中卟啉症相关基因突变的携带率和患病率。
Orphanet J Rare Dis. 2024 Sep 12;19(1):337. doi: 10.1186/s13023-024-03287-7.
2
A Novel In Vitro Assay Using Human iPSC-Derived Sensory Neurons to Evaluate the Effects of External Chemicals on Neuronal Morphology: Possible Implications in the Prediction of Abnormal Skin Sensation.一种使用人诱导多能干细胞衍生感觉神经元的新型体外分析方法,用于评估外源性化学物质对神经元形态的影响:在预测异常皮肤感觉方面的潜在意义。
Int J Mol Sci. 2021 Sep 29;22(19):10525. doi: 10.3390/ijms221910525.
3
An analysis of six cases of acute intermittent porphyria (AIP).
六例急性间歇性血卟啉病(AIP)分析。
Indian J Psychiatry. 2006 Jul;48(3):189-92. doi: 10.4103/0019-5545.31584.